| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Age-related efficacy of immunotherapies in advanced non-small cell lung cancer: a comprehensive meta-analysis
|
Ding, Yao
|
|
|
195 |
C |
p.
|
artikel
|
| 2 |
A predictive model for prognostic risk stratification of early-stage NSCLC based on clinicopathological and miRNA panel
|
Ying, Lisha
|
|
|
195 |
C |
p.
|
artikel
|
| 3 |
Asbestos Surveillance Program Aachen (ASPA): Cancer mortality among asbestos exposed power industry workers
|
Otte, Nelly
|
|
|
195 |
C |
p.
|
artikel
|
| 4 |
Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or metastatic NSCLC: Final overall survival results from a phase 2 trial
|
Lu, Shun
|
|
|
195 |
C |
p.
|
artikel
|
| 5 |
Contents
|
|
|
|
195 |
C |
p.
|
artikel
|
| 6 |
Exomic and epigenomic analysis of pulmonary blastoma
|
Alirezaie, Najmeh
|
|
|
195 |
C |
p.
|
artikel
|
| 7 |
Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk
|
Calvo, Virginia
|
|
|
195 |
C |
p.
|
artikel
|
| 8 |
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
|
Tasoudis, Panagiotis
|
|
|
195 |
C |
p.
|
artikel
|
| 9 |
Lung cancer caused by asbestos: What a reporting pathologist needs to know
|
Klebe, S.
|
|
|
195 |
C |
p.
|
artikel
|
| 10 |
Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer
|
Tamiya, Akihiro
|
|
|
195 |
C |
p.
|
artikel
|
| 11 |
MiR-137 mediated high expression of TIGD1 promotes migration, invasion, and suppresses apoptosis of lung adenocarcinoma
|
Wei, Yiqun
|
|
|
195 |
C |
p.
|
artikel
|
| 12 |
Non-invasive diagnosis of pulmonary nodules by circulating tumor DNA methylation: A prospective multicenter study
|
Li, Ying
|
|
|
195 |
C |
p.
|
artikel
|
| 13 |
Phase I/II trial of plinabulin in combination with nivolumab and ipilimumab in patients with recurrent small cell lung cancer (SCLC): Big ten cancer research consortium (BTCRC-LUN17-127) study
|
Malhotra, Jyoti
|
|
|
195 |
C |
p.
|
artikel
|
| 14 |
Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy
|
Naso, Julia
|
|
|
195 |
C |
p.
|
artikel
|
| 15 |
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma
|
Mansfield, Aaron S.
|
|
|
195 |
C |
p.
|
artikel
|
| 16 |
Real-world outcomes of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC)treated with osimertinib (osi) vs. Afatinib or erlotinib
|
Barsouk, Adam
|
|
|
195 |
C |
p.
|
artikel
|
| 17 |
Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer
|
Bauman, Jessica R.
|
|
|
195 |
C |
p.
|
artikel
|
| 18 |
1000 Robotic-assisted lobectomies for primary lung cancer: 16 years single center experience
|
Casiraghi, Monica
|
|
|
195 |
C |
p.
|
artikel
|
| 19 |
Tumor immune microenvironment of NSCLC with EGFR exon 20 insertions may predict efficacy of first-line ICI-combined regimen
|
Liu, Ke-Jun
|
|
|
195 |
C |
p.
|
artikel
|
Tijdschrift beschrijving